Guidelines for the reporting of renal artery revascularization in clinical trials

Circulation

Volumn 106, Issue 12, 2002, Pages 1572-1585

  Rundback, John H ^a   Sacks, David ^a   Kent, K Craig ^a   Cooper, Christopher ^a   Jones, Daniel ^a   Murphy, Timothy ^a   Rosenfield, Kenneth ^a   White, Christopher ^a   Bettmann, Michael ^a   Cortell, Stanley ^a   Puschett, Jules ^a   Clair, Dan ^a   Cole, Patricia ^a  

^a NONE

Author keywords

AHA Scientific Statements; Revascularization; Stenosis, renal artery; Trials

Indexed keywords

ANGIOGRAPHY; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; HEART DISEASE; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MAGNETIC RESONANCE ANGIOGRAPHY; METHODOLOGY; MORBIDITY; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; REVIEW; STENT; SURGICAL TECHNIQUE; TREATMENT FAILURE;

ANGIOPLASTY, BALLOON; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DEMOGRAPHY; GRAFT OCCLUSION, VASCULAR; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RESEARCH DESIGN; STENTS; TERMINOLOGY; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 0037126013     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000029805.87199.45     Document Type: Review

References (158)

1. Results of renal artery balloon angioplasty limit its indications
2. Restenosis after a first percutaneous transluminal renal angioplasty
3. Percutaneous transluminal renal angioplasty: Initial results and long-term follow-up in 202 patients
4. Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: Part I
5. Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: Preliminary report of a multicenter study
6. Renal artery stent placement with the use of the Wallstent endoprosthesis
7. Renal artery stenosis: Preliminary results of treatment with the Strecker stent
8. Renal artery stent placement: Long-term results with the Wallstent endoprosthesis
9. Renal artery stenosis managed by Palmaz stent insertion: Technical and clinical outcome
10. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis
11. Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis
12. Percutaneous renal artery stent placement for hypertension and azotemia: Pilot study
13. Stent placement in the renal artery: Three-year experience with the Palmaz stent
14. Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis
15. Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: Midterm technical and clinical results
16. Renal artery stent placement in renal artery stenosis: Technical and early clinical results
17. Renal artery stent placement: Utility in lesions difficult to treat with balloon angioplasty
18. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty
19. Primary stenting of atherosclerotic renal artery stenosis
20. Renal artery stent placement for the management of ischemic nephropathy
21. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis
22. Salvage of the solitary kidney by insertion of a renal artery stent
23. Stent placement in ostial and nonostial atherosclerotic renal arterial stenoses: A prospective follow-up study
24. Percutaneous transluminal renal angioplasty: Initial and long-term results
25. Percutaneous transluminal angioplasty improves blood pressure and renal function in renovascular hypertension
26. Percutaneous transluminal angioplasty vs. surgery for renovascular hypertension
27. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia
28. Cure and improvement of renovascular hypertension after percutaneous transluminal angioplasty of renal artery stenosis
29. Percutaneous angioplasty in clinical management of renovascular hypertension: Initial and long-term results
30. Follow-up study of 70 patients with renal artery stenosis treated by percutaneous transluminal dilatation
31. Azotemia caused by renal artery stenosis: Treatment by percutaneous angioplasty
32. Percutaneous transluminal angioplasty of the renal artery: Results and long-term follow-up
33. Intervention in patients with renovascular hypertension and renal insufficiency
34. Percutaneous transluminal angioplasty in complicated renal vascular hypertension
35. Failed percutaneous transluminal renal angioplasty: Experience with lesions requiring operative intervention
36. Percutaneous transluminal renal angioplasty in management of atherosclerotic renovascular hypertension: Result in 100 patients
37. Influence of age on the outcome of percutaneous angioplasty in atheromatous renovascular disease
38. Percutaneous transluminal angioplasty in the treatment of renovascular hypertension
39. Long-term results of angioplasty in 110 patients with renal artery stenosis
40. Treatment of renovascular hypertension with percutaneous transluminal angioplasty: Experience in Spain
41. Renal artery angioplasty for renovascular hypertension and preservation of renal function: Long-term angiographic and clinical follow-up
42. Percutaneous transluminal renal angioplasty in patients with renovascular hypertension: Long-term results
43. Treatment of renovascular hypertension: One year results of renal angioplasty
44. Percutaneous angioplasty for atherosclerotic renal artery disease: Effect on renal function in azotemic patients
45. Percutaneous transluminal renal angioplasty in patients with renal failure
46. Percutaneous transluminal renal angioplasty: A potentially effective treatment for preservation of renal function
47. Preservation of renal function by percutaneous renal angioplasty in high-risk elderly patients: Short-term outcome
48. Trends in surgical revascularization for renal artery disease: Ten years' experience
49. Changing patterns in surgery for chronic renal artery occlusive diseases
50. Renal failure and advance atherosclerotic lesions: Salvage by vascular reconstruction
51. Revascularization for preservation of renal function in patients with atherosclerotic renovascular disease
52. Surgical treatment of renal failure of renovascular origin
53. Reversal of end stage renal failure with surgical revascularization in patients with atherosclerotic renal artery occlusion
54. Preserving renal function by revascularization
55. Surgical management of dialysis-dependent ischemic nephropathy
56. Ischemic nephropathy and concomitant aortic disease: A ten-year experience
57. Revascularization to preserve renal function in patients with atherosclerotic renovascular disease
58. Retrieval of renal function by revascularization: Study of preoperative outcome predictors
59. Renal artery revascularization: Restoration of renal function
60. Advanced renovascular hypertension and renal insufficiency: Trends in medical comorbidity and surgical approach from 1970 to 1993
61. Renovascular reconstruction: Factors affecting long-term prognosis in 919 patients followed up to 31 years
62. Combined aortic and renal artery surgery: A contemporary experience
63. Contemporary surgical management of renovascular disease
64. Management of renovascular disease. A surgical perspective
65. Renal revascularization to preserve and restore renal function
66. Renal artery reconstruction for the preservation of renal function
67. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: A prospective randomized study
68. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomised trial
69. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis
70. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial
71. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis
72. Ethical issues in the design and conduct of randomised controlled trials
73. An introduction to the Food and Drug Administration and how it evaluates new devices: Establishing safety and efficacy
74. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices
75. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease
76. Renal artery stenosis: Anatomic classification for percutaneous transluminal angioplasty
77. Unusual renovascular disorders
78. Correlation of hemodynamic impact and morphologic degree of renal artery stenosis in a canine model
79. A prospective study of disease progression in patients with atherosclerotic renal artery disease
80. Natural history of renal artery stenosis
81. Renal Doppler, renal artery stenosis, and renovascular hypertension: Direct and indirect sonographic abnormalities in patients with renal artery stenosis
82. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis
83. Balloon angioplasty or stent placement in patients with azotemic renovascular disease: A retrospective comparison of outcomes
84. Clinical characteristics of renovascular hypertension
85. Diagnosis and evaluation of renovascular hypertension: Indications for therapy
86. Screening for renovascular hypertension
87. Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy
88. Atherosclerotic renovascular disease and progressive renal failure
89. Angiotensin converting enzyme inhibitors and renal function
90. Angiotensin-converting enzyme inhibitor-induced renal failure: Causes, consequences, and diagnostic uses
91. Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: Treatment by angioplasty or surgical revascularization
92. Renal revascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: A distinct subgroup of patients with arteriosclerotic renal artery occlusive disease
93. Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement
94. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis
95. Renal artery stenosis: Duplex US after angioplasty and stent placement
96. Using Doppler sonography to reveal renal artery stenosis: An evaluation of optimal imaging parameters
97. Prognostic significance of intrarenal resistance indices in patients with renal artery interventions: A preliminary duplex sonographic study
98. Renal arteries: Optimization of three-dimensional gadolinium-enhanced MR angiography with bolustiming-independent fast multiphase acquisition in a single breath hold
99. Renal MR angiography at 1.0 T: Three-dimensional (3D) phase-contrast techniques versus gadolinium-enhanced 3D fast low-angle shot breath-hold imaging
100. Contrast-enhanced magnetic resonance angiography of the renal arteries: Original investigation
101. Contrast-enhanced, K-space-centered, breath-hold MR angiography of the renal arteries and the abdominal aorta
102. Renal artery stenosis: CT angiography-comparison of real-time volume-rendering and maximum intensity projection algorithms
103. Spiral CT angiography of renal arteries: Comparison with angiography
104. Assessment of renal artery stenosis with CT angiography: Usefulness of multiplanar reformation, quantitative stenosis measurements, and densitometric analysis of renal parenchymal enhancement as adjuncts to MIP film reading
105. Helical CT angiography compared with arteriography in the detection of renal artery stenosis
106. Captopril radionuclide test in renovascular hypertension: A European multicentre study
107. Diagnostic criteria of renovascular hypertension with captopril renography: A consensus statement
108. The diagnosis of renovascular hypertension: The role of captopril renal scintigraphy and related issues
109. Renal artery origins: Best angiographic projection angles
110. Anatomic variation in the origin of the main renal arteries: Spiral CTA evaluation
111. Compound angulation for the angiographic evaluation of renal artery stenosis
112. Carbon dioxide digital subtraction angiography for renal artery stent placement
113. Renal insufficiency: Usefulness of gadodiamide-enhanced renal angiography to supplement CO2-enhanced renal angiography for diagnosis and percutaneous treatment
114. Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients
115. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
116. Therapeutic consequences of variation in intraarterial pressure measurements after iliac angioplasty
117. Determinants of transstenotic gradients observed during angioplasty: An experimental model
118. Sources of error in intra-arterial pressure measurements across a stenosis
119. Renal artery stenosis treated with stent deployment: Indications, technique, and outcome for 108 patients
120. Noncoronary angioplasty
121. Stents for atherosclerotic renovascular disease
122. Immediate and late outcomes after direct stent implantation without balloon predilation
123. Supraceliac aortorenal bypass with saphenous vein for renovascular hypertension
124. Aortorenal arterial autografts: The last two decades
125. Saphenous vein aortorenal bypass grafts: Serial angiographic studies
126. The contemporary role of extra-anatomic surgical renal revascularization in patients with atherosclerotic renal artery disease
127. Use of the splenic and hepatic arteries for renal revascularization
128. Techniques of operative management
129. Intraoperative assessment of renal artery and visceral artery reconstruction: The role of duplex scanning and spectral analysis
130. Intraoperative duplex sonography during renal artery reconstruction
131. Sixth Report of the Joint National Committee on Prevention, detection, evaluation, and treatment of high blood pressure
132. Human blood pressure determination by sphygmomanometry
133. International Society of Hypertension Guidelines for the Management of Hypertension: Guidelines Subcommittee
134. Assessing renal function from creatinine measurements in adults with chronic renal failure
135. Iohexol clearance for the determination of glomerular filtration rate in clinical practice: Evidence for a new gold standard
136. Estimation of glomerular filtration rate from low-dose injection of iohexol and a single blood sample
137. Capillary electrophoresis for the determination of glomerular filtration rate using nonradioactive iohexol
138. Modified plasma clearance technique using nonradioactive iothalamate for measuring GFR
139. Prediction of creatinine clearance from serum creatinine
140. Predicting glomerular function from adjusted serum creatinine
141. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
142. Complications during renal artery stent placement for atherosclerotic ostial stenosis
143. Percutaneous intravascular US as adjunct to catheter-based interventions: Preliminary experience in patients with peripheral vascular disease
144. Comparison of intravascular ultrasound, external ultrasound and digital angiography for evaluation of peripheral artery dimensions and morphology
145. Use of intravascular ultrasound improves long-term clinical outcome in the endovascular management of atherosclerotic aortoiliac occlusive disease
146. Implications of the systolic hypertension in the elderly program: The Systolic Hypertension in the Elderly Program Cooperative Research Group
147. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens
148. Guidelines for assessing outcomes of antihypertensive treatment
149. Effects of renal artery stent implantation in patients with renovascular hypertension presenting with unstable angina or congestive heart failure
150. Management of ischemic nephropathy: Dialysis-free survival after surgical repair
151. Detection, evaluation, and treatment of renovascular hypertension. Working group on renovascular hypertension. Final report
152. Percutaneous angioplasty for atherosclerotic renal artery disease: Effect on renal function in azotemic patients
153. Effect of renal artery stenting on progression of renovascular renal failure
154. Long-term outcome of surgical revascularization in ischemic nephropathy: Normalization of average decline in renal function
155. Natural history of chronic renal failure: A reappraisal
156. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease
157. Angiography and percutaneous vascular interventions: Complications and quality improvement